Welcome to our dedicated page for Solesence news (Ticker: SLSN), a resource for investors and traders seeking the latest updates and insights on Solesence stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Solesence's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Solesence's position in the market.
Solésence (Nasdaq: SLSN), a leader in scientifically-driven health care solutions focusing on beauty and life science categories, has scheduled its first quarter 2025 financial results announcement and conference call.
Key Details:
- Results Release: Monday, May 5, 2025, after market close
- Conference Call Time: 4:00 p.m. CDT / 5:00 p.m. EDT
- Key Speakers: Jess Jankowski (President & CEO) and Kevin Cureton (Chief Operating Officer)
Participants can access the conference call through multiple channels:
- Webcast: Available via media server link
- Dial-in: Registration required for personalized PIN
- Company Website: Accessible through investor relations page
Interested parties are advised to join the call at least five minutes before the start time. The company has provided convenient registration options, including an automatic dial-out feature once the conference begins.
FAQ
What is the current stock price of Solesence (SLSN)?
What is the market cap of Solesence (SLSN)?
